HRV Pharma CEO Hari Kiran Chereddi says investing in capacity at partner facilities, exploring acquisitions for market access; forecasts Rs 1,000 crore revenue in FY28
Virtual pharma API firm HRV preparing for IPO, DRHP likely in H1 of 2027: Sources
Published ·
Keep reading





